$135.070
-0.014 (-0.01%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de APGE por análisis de gráficos similares
Alphio's APGE stock price prediction model matches the current Apogee Therapeutics, Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $135.18 (+0.08%). The 1-week path is $138.58 (+2.60%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Apogee Therapeutics, Inc.?
Apogee Therapeutics Inc (APGE) is currently trading at $134.97, which is very close to the analyst price target of $135. This indicates that the stock is fairly valued at this moment. The RSI is at 82.663, suggesting that the stock is overbought, which could lead to a price correction. Additionally, the company has reported significant net income losses, with the latest quarter showing a net loss of $85,854,000. The acquisition by AbbVie for $10.9 billion could provide long-term growth potential, but the immediate financial health appears strained due to ongoing losses and high debt obligations. The main risk is the potential dilution of earnings per share by $0.14 as a result of the acquisition financing, which could impact short-term investor sentiment.
APGE cerró en $135.07 el Wednesday, tras bajar -0.01%
Apogee Therapeutics, Inc. (APGE) last closed at $135.07, losing -0.01%. These facts feed the 1-day and 1-week APGE price prediction above.
Factores de la previsión
Los factores de la previsión de Apogee Therapeutics, Inc. (APGE) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bearish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de APGE, ordenadas por similitud.
Análisis de estacionalidad de APGE
Historically the probability of a positive October return for APGE is 89.13%. November offers the highest probability of a positive month at 100.00%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de APGE
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Oct 2026 | $35.91 | $43.15 | $43.56 | -68.05% |
| Nov 2026 | $26.97 | $35.08 | $38.09 | -74.03% |
| Dec 2026 | $31.96 | $39.91 | $44.90 | -70.46% |
En 2026, se proyecta que Apogee Therapeutics, Inc. (APGE) oscile entre $26.97 y $44.90.
Previsión mensual de Apogee Therapeutics, Inc. para 2026
En Oct de 2026, se proyecta que Apogee Therapeutics, Inc. promedie $43.15, con un mínimo de $35.91 y un máximo de $43.56.
En Nov de 2026, se proyecta que Apogee Therapeutics, Inc. promedie $35.08, con un mínimo de $26.97 y un máximo de $38.09.
En Dec de 2026, se proyecta que Apogee Therapeutics, Inc. promedie $39.91, con un mínimo de $31.96 y un máximo de $44.90.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.